Spirax Group (LSE: SPX) shares fall 5.6% as unchanged 2026 outlook collides with higher investor expectations
Read More Pharma Industry News GV Safety Assessment Platform partners with Biocytogen to enhance biomedical research in India GV Safety Assessment Platform (GVSAP), a trailblazer in integrated research and development services, has announced a significant partnership… byPallavi MadhirajuMay 17, 2024